-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Intraday Session
Share
Listen to the news

Gainers

  • ELOXX PHARMA CM STK (NASDAQ:ELOX) stock rose 2364.9% to $9.12 during Tuesday's regular session.
  • Regentis Biomaterials (AMEX:RGNT) shares moved upwards by 128.9% to $2.93. The market value of their outstanding shares is at $6.6 million.
  • Nuvalent (NASDAQ:NUVL) shares increased by 39.15% to $123.14. The market value of their outstanding shares is at $6.9 billion.
  • Rafael Holdings (NYSE:RFL) shares increased by 21.47% to $1.98. The market value of their outstanding shares is at $84.7 million.
  • Cartesian Therapeutics (NASDAQ:RNAC) stock increased by 19.28% to $6.99. The company's market cap stands at $171.7 million.
  • Alignment Healthcare (NASDAQ:ALHC) stock moved upwards by 18.46% to $18.18. The company's market cap stands at $3.1 billion.

Losers

  • Aditxt (NASDAQ:ADTX) shares fell 43.3% to $0.03 during Tuesday's regular session.
  • iTonic Holdings (NASDAQ:ITOC) shares fell 28.32% to $0.36. The company's market cap stands at $8.6 million.
  • AIM ImmunoTech (AMEX:AIM) stock decreased by 25.25% to $0.39. The company's market cap stands at $7.5 million.
  • Bio Green Med Solution (NASDAQ:BGMS) stock fell 21.83% to $0.86. The market value of their outstanding shares is at $6.0 million.
  • HCW Biologics (NASDAQ:HCWB) shares decreased by 21.38% to $1.14. The company's market cap stands at $10.3 million.
  • Icecure Medical (NASDAQ:ICCM) stock fell 21.16% to $2.87. The company's market cap stands at $295.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending